Graves Light Lenhart Wealth’s Biogen BIIB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
– Sell
-24
Closed -$5K – 616
2022
Q1
$5K Sell
24
-138
-85% -$30K ﹤0.01% 585
2021
Q4
$39K Hold
162
– – 0.01% 435
2021
Q3
$46K Buy
162
+47
+41% +$15.4K 0.01% 382
2021
Q2
$40K Buy
115
+91
+379% +$27.6K 0.01% 411
2021
Q1
$7K Hold
24
– – ﹤0.01% 612
2020
Q4
$6K Buy
+24
New +$6.19K ﹤0.01% 599

Other funds holding BIIB

Graves Light Lenhart Wealth's BIIB Position: Q2 2022 in Review

Graves Light Lenhart Wealth sold out of Biogen (BIIB) in Q2 2022, closing a stake of 24 shares — an estimated $5K sold.

Graves Light Lenhart Wealth first reported a position in BIIB in Q4 2020 and held it in 6 quarters. The position peaked at $46K in Q3 2021. 927 funds tracked by Wall St. Rank hold BIIB as of Q2 2022.

  • Graves Light Lenhart Wealth reported no remaining Biogen position as of Q2 2022 after selling out during the quarter.
  • Graves Light Lenhart Wealth sold 24 Biogen shares in Q2 2022, an estimated $5K.
  • Graves Light Lenhart Wealth first reported a position in Biogen in Q4 2020 and held it in 6 quarters.
  • Graves Light Lenhart Wealth's Biogen position peaked at $46K in Q3 2021.
  • 927 funds tracked by Wall St. Rank held Biogen as of Q2 2022.

Based on Graves Light Lenhart Wealth's 13F filing for Q2 2022, filed 15 Aug 2022.